INDIUM IN-111 EPRATUZUMAB TETRAXETAN
UNII 4L3VFU7249

Substance Identification & Data

This profile provides standardized clinical and technical data for Indium In-111 Epratuzumab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4L3VFU7249.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4L3VFU7249
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INDIUM IN-111 EPRATUZUMAB TETRAXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C2217
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Indium In-111 Epratuzumab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

111IN-DOTA EPRATUZUMAB
EPRATUZUMAB TETRAXETAN INDIUM IN-111
INDIUM IN 111 LL2 IGG
INDIUM IN-111 EPRATUZUMAB TETRAXETAN

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus